| |
PRODUCT NAME |
ORDER |
 |
4(3H)-Quinazolinone, 7,8-dimethoxy-2-methyl-3-[4-(phenylmethoxy)phenyl]- |
 |
 |
4(3H)-Quinazolinone, 8-methoxy-2-methyl-7-(phenylmethoxy)-3-[3-(phenylmethoxy)phenyl]- |
 |
 |
4(3H)-Quinazolinone, 7-hydroxy-3-(3-hydroxyphenyl)-8-methoxy-2-methyl- |
 |
 |
4(3H)-Quinazolinone, 7-hydroxy-8-methoxy-3-(4-methoxyphenyl)-2-methyl- |
 |
 |
4(3H)-Quinazolinone, 7-hydroxy-3-(4-hydroxyphenyl)-8-methoxy-2-methyl- |
 |
 |
4(3H)-Quinazolinone, 8-methoxy-2-methyl-7-(phenylmethoxy)-3-[4-(phenylmethoxy)phenyl]- |
 |
 |
Benzoic acid, 4-[8-(cyclopentyloxy)-7-methoxy-2-methyl-4-oxo-3(4H)-quinazolinyl]-, ethyl ester |
 |
 |
Acetamide, N-[3-(2,3-dihydro-3-oxo-1H-pyrazol-4-yl)propyl]- |
 |
 |
3H-Pyrazol-3-one, 4-(3-aminopropyl)-1,2-dihydro-5-methyl- |
 |
 |
2H-1-Benzopyran-5-carbonyl chloride, 8-fluoro- (9CI) |
 |
 |
1-(1,2,3,6-tetrahydropyridin-4-yl)-1H-benzo[d]imidazol-2(3H)-one |
 |
 |
1,2-Propanedione, 1-(2-pyrrolidinyl)- (9CI) |
 |
 |
Bicyclo[3.1.0]hexan-6-amine, N,N-diethyl-, (1-alpha-,5-alpha-,6-b |
 |
 |
Morpholine, 4-(2-ethoxycyclohexyl)- (9CI) |
 |
 |
Benzoic acid, 3-(methylamino)-4-nitro- (9CI) |
 |
 |
3-Buten-2-one, 4-(ethylamino)-, (E)- (8CI,9CI) |
 |
 |
3-Buten-2-one, 4-(ethylamino)-, (Z)- (8CI,9CI) |
 |
 |
1,2-Benzenediol, 4-[2-(3-pyridinyl)ethyl]- (9CI) |
 |
 |
2,4-DICHLORO-5-FLUORO-1,3-XYLENE |
 |
 |
2,4-DICHLORO-3-FORMYL-5-FLUOROBENZOIC ACID |
 |
 |
Benzoyl fluoride, 3-cyano-2,4,5-trifluoro- (9CI) |
 |
 |
4-Imidazolidinecarboxylicacid,2-oxo-,(4R)-(9CI) |
 |
 |
Benzamide, N-ethyl-N-2-propenyl- (9CI) |
 |
 |
3-HYDROXY-DL-KYNURENINE |
 |
 |
1,2-Benzisoxazol-5-ol, 3-methyl- (9CI) |
 |
 |
1,2-Benzisoxazol-7-ol, 3-methyl- (9CI) |
 |
 |
4-acetyl-2-fluorobenzonitrile |
 |
 |
4-MORPHOLINOBENZYLAMINE |
 |
 |
(4-PIPERIDINOPHENYL)METHYLAMINE |
 |
 |
2-Furanmethanamine,5-chloro-(9CI) |
 |
 |
2-(1,3-Benzodioxol-5-yloxy)nicotinic acid |
 |
 |
Benzoyl chloride, 2-fluoro-6-hydroxy- (9CI) |
 |
 |
FMOC-D-4-AMINOPHENYLALANINE(BOC) |
 |
 |
Fmoc-L-Cyclopropylalanine |
 |
 |
Fmoc-D-Lys(Alloc)-OH |
 |
 |
N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-N-GAMMA-(ALLYLOXYCARBONYL)-D-ORNITHINE |
 |
 |
N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-N,-(4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONYL)-L-ARGININE |
 |
 |
N-ALPHA-T-BUTYLOXYCARBONYL-N-BETA-(2,4-DINITROPHENYL)-L-2,3-DIAMINOPROPIONIC ACID |
 |
 |
Carbamic acid, (4-hydroxy-2-butynyl)-, 1,1-dimethylethyl ester (9CI) |
 |
 |
Glycine, N,N-dimethyl-, 3-aminopropyl ester (9CI) |
 |
 |
4-Hydroxy salicylamide |
 |
 |
4-Isoxazolol,3-phenyl-(8CI,9CI) |
 |
 |
4-Aminobenzeneboronic acid pinacol ester |
 |
 |
4-PHENOXYPHENYLMAGNESIUM BROMIDE |
 |
 |
1H-Benzimidazole, 1-acetyl-2,3-dihydro- (9CI) |
 |
 |
Benzimidazole, 4-amino-5,6-dimethyl- (8CI) |
 |
 |
1H-Benzimidazole,5,6-dimethyl-4-nitro-(9CI) |
 |
 |
Glycine, N-acetyl-N-(2-hydroxyethyl)-, ethyl ester |
 |
 |
Glycine, N-(2-hydroxyethyl)-N-methyl-, ethyl ester (9CI) |
 |
 |
5(4H)-Oxazolone, 4-(2-cyclohexen-1-yl)-4-(1-methylethyl)-2-phenyl- |
 |